First Alzheimer’s injection given to SWFL woman.

The US Food and Drug Administration approved Donanemab, also known as Kisunla. The monoclonal antibody, which is meant to halt the progression of Alzheimer’s disease, was approved for sale on Tuesday.

Ivone Nascimento has the condition. She claims she gets lost while driving, even when using GPS, and fails to remember where she keeps her items, according to a recent article by Dominga Murray of FOX4.

“There’s no cure, no surgery,” she stated.

She claims she forgets stuff every few minutes.

“It’s hard… very hard,” Nascimento stated.

That is day-to-day living, but things may change today. Nascimento’s physician is Dr. W. Jamie Plante, a neurologist at The Memory Centers of Bonita Springs.

“It’s a medication that’s delivered once a month and targets the amyloid plaque in patients that have Alzheimer’s disease and breaks it down and eliminates it,” Plante told reporters.

He claims that this differs from other drugs on the market, which just treat symptoms.

“One of the most frustrating aspects of being a doctor is treating a patient and realizing there is nothing you can do. That’s an awful feeling. So now, being able to provide hope, therapy, and improve patients’ quality of life and independence makes a huge difference,” Plante added.

The medicine is made by Eli Lilly, and while it is not a cure, clinical trials have shown that it slows the course of Alzheimer’s.

Following the presentation of the study results, the FDA voted to approve the medication for market, stating that it appeared safe and effective.

According to Eli Lilly, Kisunla would cost over $700 each vial before insurance, or approximately $32,000 per year.

Ivone is hopeful that the infusion treatment will alter her life.

This article originally appeared on FOX4